Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival
1 other identifier
observational
1,782
1 country
1
Brief Summary
In recent years, several scoring systems have been developed aimed at predicting early post-LT graft function. However, many of them showed poor efficacy when long-term survivals were tested. Moreover, the necessity to find an easy-to-use score represents another obstacle, with several scores composed by numerous, difficult to find, variables. Recently, the pre-LT Balance of Risk (BAR) and the post-LT Comprehensive Complication Index (CCI) have been created, but their external validation and integration in this setting is lacking. This study aims at constructing an easy-to-use score system based on the combination of a small number of pre- and immediately post-liver transplant (LT) independent variables, in order to accurately predict long-term graft survival after LT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2018
CompletedFirst Submitted
Initial submission to the registry
October 25, 2018
CompletedFirst Posted
Study publicly available on registry
October 29, 2018
CompletedOctober 29, 2018
October 1, 2018
9 months
October 25, 2018
October 26, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Five-year post-transplant graft survival
Number of participants experiencing a graft loss for any reason
5 years
Secondary Outcomes (1)
Re-transplant rate
5 years
Study Arms (2)
Training liver transplantation
Patients consecutively transplanted in four European collaborative LT Centres (Ancona, Brussels, Rome Sapienza, and Padua) (N=1,262)
Validation liver transplantation
Patients consecutively transplanted in the Karolinska Institute (N=520)
Interventions
First deceased-donor liver transplantation
Eligibility Criteria
Adult patients transplanted for any liver pathology undergoing a first transplant.
You may qualify if:
- First transplant
- adult (\>18 years)
You may not qualify if:
- living donation
- re-transplant
- combined transplant
- domino transplant
- paediatric transplant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCL
Brussels, Belgium
Related Publications (1)
Lai Q, Melandro F, Nowak G, Nicolini D, Iesari S, Fasolo E, Mennini G, Romano A, Mocchegiani F, Ackenine K, Polacco M, Marinelli L, Ciccarelli O, Zanus G, Vivarelli M, Cillo U, Rossi M, Ericzon BG, Lerut J. The role of the comprehensive complication index for the prediction of survival after liver transplantation. Updates Surg. 2021 Feb;73(1):209-221. doi: 10.1007/s13304-020-00878-4. Epub 2020 Sep 6.
PMID: 32892294DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Quirino Lai, MD PhD
UCL Brussels
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2018
First Posted
October 29, 2018
Study Start
January 15, 2018
Primary Completion
October 15, 2018
Study Completion
October 15, 2018
Last Updated
October 29, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will not share